SE457055B - Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser - Google Patents

Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser

Info

Publication number
SE457055B
SE457055B SE8603481A SE8603481A SE457055B SE 457055 B SE457055 B SE 457055B SE 8603481 A SE8603481 A SE 8603481A SE 8603481 A SE8603481 A SE 8603481A SE 457055 B SE457055 B SE 457055B
Authority
SE
Sweden
Prior art keywords
vasopressin
mucosa
tglvp
radiation protection
gel
Prior art date
Application number
SE8603481A
Other languages
English (en)
Swedish (sv)
Other versions
SE8603481D0 (sv
SE8603481L (sv
Inventor
K F Aronsen
G Nylander
S Borgstroem
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Ab filed Critical Ferring Ab
Priority to SE8603481A priority Critical patent/SE457055B/sv
Publication of SE8603481D0 publication Critical patent/SE8603481D0/xx
Priority to AU78528/87A priority patent/AU609417B2/en
Priority to AT87850244T priority patent/ATE64308T1/de
Priority to EP87850244A priority patent/EP0265400B1/de
Priority to FI890715A priority patent/FI890715A0/fi
Priority to PCT/SE1987/000359 priority patent/WO1988001163A1/en
Priority to DE8787850244T priority patent/DE3770753D1/de
Priority to JP62504940A priority patent/JPH02500668A/ja
Priority to IL83566A priority patent/IL83566A/xx
Publication of SE8603481L publication Critical patent/SE8603481L/
Priority to NO881580A priority patent/NO881580L/no
Priority to DK206688A priority patent/DK206688A/da
Publication of SE457055B publication Critical patent/SE457055B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Support Of Aerials (AREA)
  • Details Of Aerials (AREA)
  • Cosmetics (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Colloid Chemistry (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
SE8603481A 1986-08-18 1986-08-18 Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser SE457055B (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE8603481A SE457055B (sv) 1986-08-18 1986-08-18 Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
JP62504940A JPH02500668A (ja) 1986-08-18 1987-08-14 粘膜用局部的放射線防護ゲル
FI890715A FI890715A0 (fi) 1986-08-18 1987-08-14 Topikalt, mot straolning skyddande gel foer slemhinnor.
AT87850244T ATE64308T1 (de) 1986-08-18 1987-08-14 Topisches gel zum schutz von schleimhaeuten bei bestrahlungen.
EP87850244A EP0265400B1 (de) 1986-08-18 1987-08-14 Topisches Gel zum Schutz von Schleimhäuten bei Bestrahlungen
AU78528/87A AU609417B2 (en) 1986-08-18 1987-08-14 Topical radioprotective gel for mucosa
PCT/SE1987/000359 WO1988001163A1 (en) 1986-08-18 1987-08-14 Topical radioprotective gel for mucosa
DE8787850244T DE3770753D1 (de) 1986-08-18 1987-08-14 Topisches gel zum schutz von schleimhaeuten bei bestrahlungen.
IL83566A IL83566A (en) 1986-08-18 1987-08-17 Radioprotective gel containing vasoconstrictors for topical application on mucosa
NO881580A NO881580L (no) 1986-08-18 1988-04-12 Lokal straalingsbeskyttende gel for slimhinne.
DK206688A DK206688A (da) 1986-08-18 1988-04-15 Topisk straalebeskyttende gel for mucosa

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8603481A SE457055B (sv) 1986-08-18 1986-08-18 Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser

Publications (3)

Publication Number Publication Date
SE8603481D0 SE8603481D0 (sv) 1986-08-18
SE8603481L SE8603481L (sv) 1988-02-19
SE457055B true SE457055B (sv) 1988-11-28

Family

ID=20365336

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8603481A SE457055B (sv) 1986-08-18 1986-08-18 Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser

Country Status (11)

Country Link
EP (1) EP0265400B1 (de)
JP (1) JPH02500668A (de)
AT (1) ATE64308T1 (de)
AU (1) AU609417B2 (de)
DE (1) DE3770753D1 (de)
DK (1) DK206688A (de)
FI (1) FI890715A0 (de)
IL (1) IL83566A (de)
NO (1) NO881580L (de)
SE (1) SE457055B (de)
WO (1) WO1988001163A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988005661A1 (en) * 1987-01-30 1988-08-11 Biomed Research Consultants, Limited Vasopressin-based pharmaceutical compositions
ATE177939T1 (de) * 1987-10-22 1999-04-15 Procter & Gamble Chelatbildner enthaltende lichtschutzmittel
US7173011B2 (en) 2000-11-20 2007-02-06 University Of Southern California Radiation therapy methods
US6455500B1 (en) 1998-03-10 2002-09-24 University Of Southern California Radiation therapy methods
EP1061937A1 (de) * 1998-03-10 2000-12-27 University Of Southern California Verbesserte methode für die strahlentherapie
WO2002034235A1 (en) * 2000-10-27 2002-05-02 Leo Pharma A/S Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
US7625928B2 (en) 2002-10-01 2009-12-01 Mitos Pharmaceuticals, Inc. Nitroxide radioprotector formulations and methods of use
CA2557520C (en) * 2003-02-26 2011-09-13 Donald W. Landry A method for stabilizing blood pressure in hemodialysis subjects
JO2937B1 (en) 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
PT2656860T (pt) 2005-06-17 2021-07-28 Wisconsin Alumni Res Found Preparações vasoconstritoras tópicas e métodos para proteção de células durante a quimoterapia e a radioterapia do cancro
US8883965B2 (en) 2006-02-10 2014-11-11 Ferring B.V. Compounds
EP2175874A2 (de) 2007-08-14 2010-04-21 Ferring B.V. Verwendung von peptidischen vasopressin-rezeptoragonisten
EP2890361A2 (de) * 2012-10-16 2015-07-08 Rohm and Haas Company Wässrige gele mit weichmachern

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2785103A (en) * 1953-12-31 1957-03-12 Abbott Lab L-desoxyephedrine inhalant preparation
CH455823A (de) * 1964-08-01 1968-05-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung von Peptiden
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
DE3106619A1 (de) * 1981-02-23 1982-09-09 Klaus-Dieter Dr. 3550 Marburg Bremecker Pharmazeutische zubereitung in form eines mikroklysmas

Also Published As

Publication number Publication date
NO881580D0 (no) 1988-04-12
EP0265400B1 (de) 1991-06-12
FI890715L (fi) 1989-02-15
JPH02500668A (ja) 1990-03-08
IL83566A0 (en) 1988-01-31
DK206688A (da) 1988-06-13
AU609417B2 (en) 1991-05-02
SE8603481D0 (sv) 1986-08-18
WO1988001163A1 (en) 1988-02-25
SE8603481L (sv) 1988-02-19
FI890715A7 (fi) 1989-02-15
EP0265400A3 (en) 1988-11-09
DK206688D0 (da) 1988-04-15
EP0265400A2 (de) 1988-04-27
DE3770753D1 (de) 1991-07-18
NO881580L (no) 1988-05-30
FI890715A0 (fi) 1989-02-15
IL83566A (en) 1991-06-10
ATE64308T1 (de) 1991-06-15
AU7852887A (en) 1988-03-08

Similar Documents

Publication Publication Date Title
Fassoulaki et al. Intransal adminstration of nitroglycerine attenuates the pressor responsive to laryngoscopy and intubation of the trachea
Stoney et al. The incidence of venous thrombosis following long-term transvenous pacing
Grondin et al. Influence of a critical coronary artery stenosis on myocardial protection through cold potassium cardioplegia
UA77640C2 (uk) Водна фармацевтична композиція для нанесення на слизову оболонку носа
Kerr et al. Suppression of ventricular arrhythmias after coronary artery ligation by pinacidil, a vasodilator drug
EP0265400B1 (de) Topisches Gel zum Schutz von Schleimhäuten bei Bestrahlungen
US4832954A (en) Nicorandil containing external preparations
Hilton et al. Perfusion of the isolated adrenals in situ
Altura Evidence that endogenous vasopressin plays a protective role in circulatory shock. Role for reticuloendothelial system using Brattleboro rats
Fagbemi et al. Antiarrhythmic actions of meptazinol, a partial agonist at opiate receptors, in acute myocardial ischaemia
Fawaz Effect of reserpine and pronethalol on the therapeutic and toxic actions of digitalis in the dog heart-lung preparation
Huang et al. Beneficial effects of berberine on hemodynamics during acute ischemic left ventricular failure in dogs
Bixler et al. Effects of procaine-induced cardioplegia on myocardial ischemia, myocardial edema, and postarrest ventricular function: a comparison with potassium-induced cardioplegia and hypothermia
Aggarwal et al. Phrenic nerve palsy: a rare complication of indwelling subclavian vein catheter.
Jastremski et al. Femoral venous catheterization during cardiopulmonary resuscitation: a critical appraisal
Curtis et al. Actions of the verapamil analogues, anipamil and ronipamil, against ischaemia-induced arrhythmias in conscious rats
Nahor et al. Effect of celiac blockade and dibenzyline on traumatic shock following release of occluded superior mesenteric artery
Flensted‐Jensen et al. LIDOCAINE AS AN ANTIARRHYTHMIC AGENT: Experience in 68 patients
Hatori et al. Coronary venous retroinfusion of felodipine reduces myocardial necrosis after coronary occlusion and reperfusion
WILSON et al. In extremis use of a Foley catheter in a cardiac stab wound
Goerg et al. Azodisalicylate (Azodisal Sodium) Causes Intestinal Secretion: Comparative Study of the Effect of Azodisalicylate, Sulfasalazine, 5-Aminosalicylic Acid and Sulfapyridine on the Water and Electrolyte Transfer and the Morphology of the Rat Ileum and Colon in vivo
Ebert et al. Effect of neurogenic reflexes on heart rate during systemic hypotension
WO2020205459A1 (en) Polymer agents for cardiopulmonary resuscitation
Chinushi et al. Ventricular tachycardia initiated by high energy cardioversion in a patient with an implantable cardioverter defibrillator
RU2371183C2 (ru) Трансдермальные стероидные композиции

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8603481-6

Effective date: 19920306

Format of ref document f/p: F